Luisella Righi

MD, PhD. Wife, Mum. #pathologist #lungpath #cytopath

[EJR_official @EJR_official_]

🔎 CT-guided TTNB: How We Do It
💡 A must-read on the essentials of transthoracic needle biopsy (TTNB):
✔️ Key for diagnosing lung lesions & tumor biomarkers
✔️ Radiologist’s role is central in planning & selection

📖 Read the full article: https://t.co/fHOZmpsFaQ
#LungNeoplasm

[giovanni farinea @FarineaGiovanni]

Happy to present my poster on #PARPi and #IO synergism in #MPM: Results from the UNITO trial. #ELCC25 @myESMO @PassigliaFra @lullirighi

[WALCE APS @WalceOnlus2006]

Prosegue anche nel 2025 #EPROPA (European Program for ROutine testing of Patients with Advanced lung cancer) 👇

[Luisella Righi @lullirighi]

So proud!!!!
Thanks to #silvianovello @PassigliaFra #angelalistí @marialuciareale @Faber_MDPhD @UmbertoMalapel1 @giorgioscaglio3 #paolobironzo @WalceOnlus2006 @ClaudioSini9 @DanielePignata3

[Maria Lucia Reale @marialuciareale]

Just out in @JTOonline
EPROPA: a program addressed to European patients with oncogene-addicted advanced NSCLC to increase the opportunities of molecular diagnostics and facilitate the access to clinical trials. @PassigliaFra @lullirighi @WalceOnlus2006

https://t.co/Gb8KT5b3PG

[Maria Lucia Reale @marialuciareale]

Just out in @JTOonline
EPROPA: a program addressed to European patients with oncogene-addicted advanced NSCLC to increase the opportunities of molecular diagnostics and facilitate the access to clinical trials. @PassigliaFra @lullirighi @WalceOnlus2006

https://t.co/Gb8KT5b3PG

[WALCE APS @WalceOnlus2006]

@PassigliaFra @merlini_ale @Faber_MDPhD @marialuciareale @ClaudioSini9 @DanielePignata3 @LuisPaz_Ares @EnriquetaFelip @NevenaSecen @Alina_Comanescu @kleidamati @ElinardouHelena @ValloneStefania @UmbertoMalapel1 @lullirighi @giorgioscaglio3 #SilviaNovello

[Stephen V Liu, MD @StephenVLiu]

An unforgettable faculty dinner with the VIII Conferenza Oncologia Polmonare in Bari, Italy chaired by @galetta2, learning to make orecchiette from Nunzia with @marialuciareale @lullirighi @mirkomontrone @PrelajArsela @roccotrisolini and other friends!

[Noemi Reguart @NReguart]

#ESMO24 @JordiRemon elegantly presenting PECATI phase 2 lenvatinib plus pembro in pretreated B3-thymoma and thymic carcinoma. Primary endpoint met 5-mo PFS 88%. Promising 12-mo OS 85%. Higher dose intensity associated with better outcomes. Manageable safety BUT irAE 14%.

[Benjamin Besse @BenjaminBesseMD]

Impressive benefit for Lenvatinib-Pembrolizumab in pts with thymic carcinoma and B3 thymoma. ORR 23.3% and mPFS 14.9m are unexpected in 2nd line or more.
Lenvatinib dose matters in a subgroup analysis. Congratulations @JordiRemon #ESMO24

[Jordi Remon @JordiRemon]

Thymic Epithelial Tumors remain a rare and orphan disease. Results of PECATI trial may help to ⬆️ patient outcomes with metastatic B3Thymoma and Thymic Carcinoma. Multidisciplinary approach is also crucial for these rare tumours #ESMO24

[Luisella Righi @lullirighi]

@BiagioRicciutMD @DanaFarber @DanaFarberNews @DFarberThoracic @IREISGufficiale @harvardmed @VJOncology Great work @BiagioRicciutMD !!

[Claudio Bellevicine @pathologyfinder]

Italian Cytopath session @ #ECC24 about inter-observer variability in cytopathology chaired by @giankitronky and @DianaEstherossi

[@ᴛᴏʀᴀᴋᴊᴋᴊ @Torakjkj]

Si dice che #Meloni sia molto irritata dalla condivisione virale di questa immagine.
Dovremmo smettere di postarla, non retwittate.

[Luisella Righi @lullirighi]

@elonmuskADO Twitter

[Andrew Rosenkrantz @arosenkrantzmd]

New @AJR_Radiology Accepted Manuscript:

"CT-Guided Core-Needle Biopsy of Pulmonary Lesions Associated With Cystic Airspaces: A Case-Control Study"

By Dr Balbi & team @unito

https://t.co/5lJm2i1BNn

[Luisella Righi @lullirighi]

@PasqualePisapia @JPM_MDPI @UmbertoMalapel1 @MarcelloTiseo @OncoAlert @4oncommunity 🙏

[Pasquale Pisapia @PasqualePisapia]

I am very proud to share our review published on @JPM_MDPI. Thanks to all Co-Authors and in particular to #Giulio_Rossi for his vision and mentorship. @lullirighi @UmbertoMalapel1 @MarcelloTiseo @OncoAlert @4oncommunity https://t.co/JazkUgCxzd

[Jordi Remon @JordiRemon]

In this #ASCO Educational Book📕 we summarize in EGFR mut🫁:
✏️New EGFR TKI options in early stage
✏️New options in metastatic setting
✏️Mechanisms of acquired resistance and new drugs 🧬
online at https://t.co/Vg3mZrceyk
Thanks to @stephanieplsaw @LeXiuning @HendriksLizza

[Luisella Righi @lullirighi]

@JordiRemon @stephanieplsaw @LeXiuning @HendriksLizza Very useful review! Congrats Jordi!